Titration of Hepatitis C Virus in Chimpanzees for Determining the Copy Number Required for Transmission

• Published in: Intervirology Vol. 47; no. 1; pp. 57 - 64
• Main Authors: Katayama, Keiko, Kumagai, Junko, Komiya, Yutaka, Mizui, Masaaki, Yugi, Hisao, Kishimoto, Shinya, Yamanaka, Retsuji, Tamatsukuri, Shigeru, Tomoguri, Tetsushi, Miyakawa, Yuzo, Tanaka, Junko, Yoshizawa, Hiroshi
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01.01.2004
• Subjects: Animals; Female; Hepacivirus - isolation & purification; Hepatitis C - transmission; Hepatitis C Antibodies - blood; Hepatitis C virus; Male; Nucleic Acid Amplification Techniques; Original Paper; Pan troglodytes - virology; RNA, Viral - blood; Polymerase chain reaction; Transfusion; Blood products; Hepatitis C virus; Minimal infectious (virus) titer; Chimpanzee
• ISSN: 0300-5526; 1423-0100
• DOI: 10.1159/000076643

Objective: To determine the copy number of hepatitis C virus (HCV) RNA, determined by nucleic acid amplification test (NAT) for screening blood units in Japan, that can transmit infection to chimpanzees. Methods: Fresh-frozen plasma with markers of HCV infection, as well as inocula pedigreed from 1 of them, were evaluated for the infectious activity in chimpanzees. Results: One unit each (273–282 ml) of fresh-frozen plasma from 2 blood donors or a pool from 13 donors to make a unit, which contained high-titered antibody to HCV but without HCV RNA detectable by NAT, did not infect any of 3 chimpanzees. Two chimpanzees were infected, however, when they were inoculated with 1 ml of serum from a blood donor in the ‘window period’ of HCV infection and containing 7.0 × 10 6 copies/ml of HCV RNA. The preacute phase serum from 1 of them harvested 7 weeks after the inoculation was titrated in 2 chimpanzees, and an inoculum containing approximately 2 × 10 1 copies of HCV RNA could transmit infection to both of them. Conclusion: Approximately 20 copies of HCV can transmit infection to recipients, which needs to be taken into consideration in planning the screening of blood units for HCV RNA by NAT. Although the sensitivity of present NAT could be improved further, there would be a limit of it in detecting a low-level HCV RNA in the window period of donors with the infectious capacity in recipients.